Apyx Medical Corporation Reports Second Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/9/2026
- US stock futures dip as oil breaches $100 mark for the first time since mid-year
- Oil nears $100 as fresh Middle East strikes raise supply risks
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- Harry and Meghan surprised by King Charles' letter on their status
- Citi initiates UiPath coverage with Buy rating and $23 target
- S&P 500 falls as AI worries hit software makers
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- After an 18% summer selloff in chip stocks, Citi asks what comes next
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Apyx Medical Corp. (APYX) Tops Q2 EPS by 7c, Revenues Beat
August 10, 2020 7:17 AM EDTApyx Medical Corp. (NASDAQ: APYX) reported Q2 EPS of ($0.14), $0.07 better than the analyst estimate of ($0.21). Revenue for the quarter came in at $4.3 million versus the consensus estimate of $1.96 million.
Second Quarter 2020 Financial Summary:
Total revenue of $4.3 million, down 35% year-over-year.Advanced Energy revenue of $2.9 million, down 46% year-over-year.OEM revenue of $1.4 million, up 10% year-over-year.GAAP net loss of $4.7 million, compared to total GAAP net loss of $4.3 million for the second quarter of 2019.Adjusted EBITDA loss of $4.9 million, compared to adjusted EBITDA loss of $3.6 million for the second... More